eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2024
vol. 26
 
Share:
Send email
Share:
abstract:
Review paper

Polish expert group recommendations for RSV vaccination in adults

Aneta Nitsch-Osuch
1
,
Adam Antczak
2
,
Adam Barczyk
3
,
Leszek Czupryniak
4
,
Marcin Grabowski
5
,
Maciej Kupczyk
6
,
Justyna Ledwoch
7
,
Agnieszka Mastalerz-Migas
8
,
Michał Sutkowski
9
,
Filip Szymański
10
,
Jacek Wysocki
11

  1. Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland; Polish Society of Family Medicine
  2. Department of General and Oncological Pulmonology, Medical University of Lodz, Lodz, Poland
  3. Chair and Department of Pneumology, Medical University of Silesia in Katowice, Katowice, Poland; Polish Society of Lung Diseases
  4. Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland; Polish Diabetes Association
  5. Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
  6. Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland; Polish Society of Allergology
  7. Polish Society of Family Medicine
  8. Department of Family Medicine, Wroclaw Medical University, Wroclaw, Poland; Polish Society of Family Medicine
  9. Łazarski University, Warsaw; Warsaw, Poland; College of Family Physicians in Poland
  10. Chair of Civilization Diseases, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University in Warsaw, Warsaw, Poland; Polish Cardiac Society
  11. Department of Preventive Medicine, Poznan University of Medical Sciences, Poznan, Poland; Polish Vaccinology Society
Family Medicine & Primary Care Review 2024; 26(3): 402–407
DOI: https://doi.org/10.5114/fmpcr.2024.142015
Online publish date: 2024/09/30
View full text Get citation
 
PlumX metrics:
Respiratory syncytial virus (RSV) causes acute lower and upper respiratory tract infections in all age groups. The clinical course of RSV infection differs depending on age and comorbidities. RSV infections are severe in the adult population; the highest risk of complications is seen in the elderly (age over 60 years) and in individuals with certain chronic disorders. Vaccination is the only currently available method of active prevention of RSV infections in adults. RSV vaccines stimulate both the humoral and the cell-mediated immunity and ensure a high level of protection against severe and complicated infection. Vaccination is recommended in all patients over the age of 60 years, particularly those with chronic disease (asthma, chronic obstructive pulmonary disease and other chronic respiratory tract disorders, ischaemic heart disease, heart failure, cardiac arrhythmias, diabetes, chronic kidney disease), immunodeficient individuals and nursing home residents.
keywords:

Respiratory Syncytial Viruses, respiratory tract infections, vaccination

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.